Abirateron Sandoz 250 mg, Filmtabletten - 120 Swissmedic Key 67818001 Registration Holder Sandoz Pharmaceuticals AG Name Abirateron Sandoz 250 mg, Filmtabletten Date of registration 26.10.2021 Introduction of Sequence 26.10.2021 ATC-Classification Abiraterone (L02BX03) Revision date WHO WHO-DDD Valid until 25.10.2026 Index Therapeuticus (BSV) 07.16.20. Show package size 120 Index Therapeuticus (Swissmedic) 07.16.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680678180018 Medication Code Synthetika Pharmacode Disponibility
Composition abirateroni acetas 250 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 30, cellulosum microcristallinum, lactosum monohydricum 34 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, pro compresso obducto corresp. natrium 5.31 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Abirateroni Acetas 250 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Lactose Monohydrate 34 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Povidonum K 30 Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 05.05.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :